Page last updated: 2024-12-07

precirol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

precirol: octadecanoic acid esters; 2,3-dihydroxypropyl ester mixed with 3-hydroxy-2-((1-oxohexadecyl)oxy)propyl octadienoate & 2-((1-oxohexadecyl)oxy)-1,3-propanediol; auxiliary in tableting; alpha glycerol palmitostearate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114690
SCHEMBL ID542237
MeSH IDM0053400

Synonyms (9)

Synonym
octadecanoic acid, ester with 1,2,3-propanetriol hexadecanoate
precirol
einecs 232-514-8
glyceryl palmitostearate
8067-32-1
gsy51o183c ,
unii-gsy51o183c
SCHEMBL542237
FT-0699569

Research Excerpts

Bioavailability

Nanostructured lipid carriers (NLCs) made from mixtures of Precirol and squalene were prepared to investigate whether the bioavailability of lovastatin can be improved by oral delivery.

ExcerptReferenceRelevance
"Nanostructured lipid carriers (NLCs) made from mixtures of Precirol and squalene were prepared to investigate whether the bioavailability of lovastatin can be improved by oral delivery."( Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen, CC; Fang, JY; Huang, ZR; Tsai, TH, 2010
)
0.6
"This provided an increase in relative oral bioavailability of 1500% after a single oral administration of drug-loaded LNs, maintaining edelfosine plasma levels over 7 days in contrast to a single oral administration of edelfosine solution, which presented a relative oral bioavailability of 10%."( Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles.
Blanco-Prieto, MJ; Campanero, MA; de la Iglesia-Vicente, J; Estella-Hermoso de Mendoza, A; Lana, H; Mollinedo, F; Villa-Pulgarin, JA, 2012
)
0.38
" The bioavailability of CsA was matched and even enhanced with Precirol nanoparticles."( Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studies.
Blanco-Prieto, MJ; Dios-Viéitez, Mdel C; Guada, M; Lana, H; Lasa-Saracíbar, B, 2016
)
0.67
" In this work, we report that PEGylation of the nanocarriers increases drug intracellular bioavailability leading therefore to higher therapeutic efficacy."( Self-assembly PEGylation assists SLN-paclitaxel delivery inducing cancer cell apoptosis upon internalization.
Arranja, A; Gener, P; Gouveia, LF; Pereira, C; Rafael, DF; Schwartz, S; Videira, MA, 2016
)
0.43
"A solid lipid nanoparticle (SLN) formulation was developed with the aim of improving the oral bioavailability and the therapeutic effectiveness of glibenclamide (GLI), a poorly water-soluble drug used in the treatment of type 2 diabetes."( Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.
Almeida, AJ; Di Cesare Mannelli, L; Ghelardini, C; Gonçalves, LM; Maestrelli, F; Mura, P, 2016
)
0.43
" Although oral formulations are clinically available, the lower bioavailability (<2%) embarrasses the pharmaceutists."( Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
Du, X; Gao, N; Song, X, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" When used in relatively high quantities, Precirol ATO 5 imparts sustained-release properties to solid oral dosage forms, by forming a lipid matrix."( Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
Chambin, O; Jannin, V; Pochard, E, 2006
)
0.81
" An increase of urinary excretion of riboflavin was observed when the volunteers were dosed with the floating pellets, especially after feeding."( In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
Amighi, K; Goole, J; Hamdani, J; Moës, AJ, 2006
)
0.33
" However, they might be useful for taste-masking in solid dosage forms."( Solid lipid microparticles containing loratadine prepared using a Micromixer.
Medlicott, N; Milak, S; Tucker, IG, 2006
)
0.33
"The applicability of the solid lipid extrusion process as preparations method for sustained release dosage forms was investigated in this study."( Solid lipid extrusion of sustained release dosage forms.
Kleinebudde, P; Reitz, C, 2007
)
0.34
" The results clearly indicate that the physico-chemical properties of the drug and the matrix systems are crucial for the design of ethanol-resistant dosage forms."( Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids.
Feichtinger, A; Jedinger, N; Khinast, J; Mohr, S; Roblegg, E; Schrank, S, 2015
)
0.42
" This study aims at designing a novel dosage form of sustained release taste-masked QT orally disintegrating tablets (ODTs) based on solid lipid micro-pellets (SLMPs)."( A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets.
Boraei, N; Ismail, F; Refaat, A; Sokar, M, 2016
)
0.43
"Antiemetic agent Meclizine HCl, widely prescribed in vertigo, is available only in immediate release dosage forms."( Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
Ahmad, M; Ahmed, K; Nasiri, MI; Qazi, F; Shoaib, MH; Yousuf, RI, 2017
)
0.46
"Protein drugs may encounter conformational perturbations during the formulation processing of lipid-based solid dosage forms."( Attenuated Total Reflection Fourier Transform Infrared (ATR FT-IR) Spectroscopy as an Analytical Method to Investigate the Secondary Structure of a Model Protein Embedded in Solid Lipid Matrices.
Jorgensen, L; Medlicott, NJ; Tabbassum, M; Zeeshan, F, 2018
)
0.48
"In the last decade 3D printing (3DP) technology has gained increasing interest in the pharmaceutical field addressing several novel challenges such as on-demand manufacturing at the point of need, customization of drug release profiles and patient-specific solutions as well as combinations of several APIs in one dosage form."( Partial tablet coating by 3D printing.
Bettini, R; Rekkas, DM; Tsintavi, E, 2020
)
0.56
" RLX fails to be developed into injectable dosage forms due to poor solubility."( Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
Du, X; Gao, N; Song, X, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (79)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (3.80)18.7374
1990's1 (1.27)18.2507
2000's21 (26.58)29.6817
2010's50 (63.29)24.3611
2020's4 (5.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.75 (24.57)
Research Supply Index4.41 (2.92)
Research Growth Index6.10 (4.65)
Search Engine Demand Index50.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other81 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]